GSK’s RSV Vaccine Approved for More Adults, Easing Healthcare Pressure
On Friday, the Food and Drug Administration (FDA) gave GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, an expanded approval. This […]
On Friday, the Food and Drug Administration (FDA) gave GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, an expanded approval. This […]
A new drug called zorevunersen, developed by Biogen and Stoke Therapeutics, has shown potential to be the first treatment that
Scientists in Korea have created a new way to clean water using special ceramic filters. These filters can remove tiny,
A company called Kyowa Kirin has decided to stop all trials of a new eczema drug called rocatinlimab. This drug
A recent study has shown a new way to treat water using nanofiltration. This technology could make ceramic-based water filters
Moderna has agreed to pay up to $2.25 billion to settle a long-running legal dispute with Arbutus Biopharma and Genevant
Stay informed with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the world of drug development, business deals
Merck & Co. has long been known for its cancer drug Keytruda. But with Keytruda’s patents set to expire soon,
Nonprofit organizations are playing a big role in developing treatments for rare diseases, especially when big companies aren’t interested. Gene
Super Bowl ads often set cultural trends, and this year, AI was a hot topic with about 23% of commercials